Retina-focused research update introducing laboratory advances and their implications for modeling disease and guiding future vision-therapy development.
Key Takeaways
- Researchers generated human retinal endothelial cells from iPSCs using a custom growth-factor protocol
- Lab-grown cells modeled diabetic retinopathy breakdown under hypoxia and high-glucose conditions
- Injected cells integrated into diseased mouse retinas and restored vascular structure and function